Back to search
FDAFDA · Food and drugs·Recall number D-1497-2022

Triamcinolone Acetonide Cream USP, 0.1%, 80 g tube, Rx Only, Manufactured By Perrigo, Bronx, NY 10457, Distributed By Perrigo, Allegan, MI 49010, NDC 45802-064-36.

Published September 7, 2022 · Recall initiated: August 17, 2022

Summary

FDA records drug Class II recall D-1497-2022, published September 7, 2022 and initiated August 17, 2022. Recalling firm: Padagis US LLC; Status: Terminated; Reported quantity: 57,816 tubes; Lot: Lot 2CT0486 , Exp 02/29/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness.

What to do

Voluntary: Firm initiated · Letter

Get an email if TRIAMCINOLONE ACETONIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
TRIAMCINOLONE ACETONIDE
Manufacturer
Padagis US LLC
Distributor
Nationwide in the USA
Lot
Lot 2CT0486 , Exp 02/29/2024
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Triamcinolone Acetonide Cream USP, 0.1%, 80 g tube, Rx Only, Manufactured By Perrigo, Bronx, NY 10457, Distributed By Perrigo, Allegan, MI 49010, NDC 45802-064-36. recalled?

Yes. FDA published recall D-1497-2022 on September 7, 2022. Reported hazard: CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: TRIAMCINOLONE ACETONIDE.